Introduction: Focused ultrasound is now well known to urologists in the con
text of its validated application in extracorporeal lithotripsy. High Inten
sity Focused Ultrasound (HIFU) represents a potential therapeutic modality
for tissue destruction due to its very high energy and its capacity to prec
isely reach a target with a very short emission time. The authors review th
e current state of art of HIFU in urology at a time when its indication in
prostate cancer is being defined.
Material and Method: After a brief description of the main physical princip
les of ultrasound and the main data determining focussing of high energy ul
trasound, the main machines available (research and clinical) are described
. The published clinical literature concerning the tissue destructive actio
n in urology is reviewed.
Results: HIFU has been used in urology to treat renal, vesical, prostatic (
BPH and cancer), and external genital organ lesions. Purely extracorporeal
machines are gradually being replaced by intracorporeal procedures, especia
lly transrectal techniques for prostatic lesions. The quality of ultrasound
detection of the target still limits the use of this minimally invasive mo
dality. The intervening tissues are spared with a good therapeutic efficacy
on the target tissues, provided optimal firing parameters are used.
Conclusion: HIFU has a demonstrated potential in the treatment of prostate
cancer and studies conducted by several teams have defined the technique an
d its efficacy. Other indications have been studied, but must be validated
by further clinical trials. The future will probably see the design of mach
ines adapted to a specific target tissue rather than a single multidiscipli
nary extracorporeal machine.